JARDIN PHARMA BERHAD 1. ) SME BANK BHD 2. ) SMEB ASSET MANAGEMENT SDN BHD 3. ) XORIX SDN BHD (Dalam Penerimaan) 4. ) AZMY BIN A HAMID 5. ) ABDUL HALIM BIN MOHAMAD 6. ) RINOL AZHAR BIN RIDZUAN 7. ) SYED REDZUAN BIN SYED SALIM SHATRI 8. ) KAM
Jardin lacks standing to maintain a direct ultra vires challenge because statutory remedies (s346 or leave under s347) must be followed; Xorix's pharmaceutical activities fall within its broadly drafted objects and are not ultra vires; the 2006–2009 financing agreements remain valid and enforceable, protected by s20(1) Companies Act 1965 as preserved by s620(4) Companies Act 2016; Receivers and Managers have locus standi to defend and the interlocutory injunction is refused (no serious issue, damages adequate, balance of convenience favours secured creditors); OS and injunction dismissed with costs.
- Citation
- WA-24NCC-387-08/2024 (Mahkamah Tinggi)
- Parties
- Plaintiff: Jardin Pharma Berhad; 1st Defendant: SME Bank Bhd; 2nd Defendant: SMEB Asset Management Sdn Bhd; 3rd Defendant: Xorix Sdn Bhd (In Receivership); 4th Defendant: Azmy Bin A Hamid; 5th Defendant: Abdul Halim Bin Mohamad; 6th Defendant: Rinol Azhar Bin Ridzuan; 7th Defendant: Syed Redzuan Bin Syed Salim Shatri; 8th Defendant: Kamaruddin Bin Mat Desa
- Court
- High Court
- Jurisdiction
- Malaysia
- Judgment Date
- 15 November 2024
- Case Number
- WA-24NCC-387-08/2024 (Mahkamah Tinggi)
- Procedural Posture
- Originating Summons (commercial Division) / Judgment (final Determination on OS and Interlocutory Injunction)
- Outcome
- Originating Summons dismissed with costs; interlocutory injunction application dismissed with costs; ad interim injunction discharged.
- Legal Topics
- Ultra Vires, Locus Standi, Interlocutory Injunction, Section 20(1) Companies Act 1965, Section 35 Companies Act 2016, Derivative Action (section 347), Res Judicata, Receivers and Managers' Duties
- Source Language
- Malay/English
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Jardin Pharma Berhad
Plaintiff
SME Bank Bhd
1st Defendant
SMEB Asset Management Sdn Bhd
2nd Defendant
Xorix Sdn Bhd (In Receivership)
3rd Defendant
Azmy Bin A Hamid
4th Defendant
Abdul Halim Bin Mohamad
5th Defendant
Rinol Azhar Bin Ridzuan
6th Defendant
Syed Redzuan Bin Syed Salim Shatri
7th Defendant
Kamaruddin Bin Mat Desa
8th Defendant
Procedural Posture
Originating Summons (commercial Division) / Judgment (final Determination on OS and Interlocutory Injunction)
Legal Issues
- 1 Whether the Receivers and Managers have locus standi to appear
- 2 Whether shareholder (Jardin) has standing to challenge historic ultra vires transactions
- 3 Whether Xorix's pharmaceutical activities were ultra vires its objects clause
Ratio Decidendi
Jardin lacks standing to maintain a direct ultra vires challenge because statutory remedies (s346 or leave under s347) must be followed; Xorix's pharmaceutical activities fall within its broadly drafted objects and are not ultra vires; the 2006–2009 financing agreements remain valid and enforceable, protected by s20(1) Companies Act 1965 as preserved by s620(4) Companies Act 2016; Receivers and Managers have locus standi to defend and the interlocutory injunction is refused (no serious issue, damages adequate, balance of convenience favours secured creditors); OS and injunction dismissed with costs.
Court Disposition
Originating Summons dismissed with costs; interlocutory injunction application dismissed with costs; ad interim injunction discharged.
Orders
- Originating Summons WA-24NCC-387-08/2024 dismissed with costs in favour of the 1st to 3rd and other defendants
- Notice of Application for Injunctive Relief (Enclosure 4) dismissed with costs
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment